VIROPHARMA INC (VPHM) financial statements (2021 and earlier)

Company profile

Business Address 730 STOCKTON DRIVE
EXTON, PA 19341
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments247
Cash and cash equivalents176
Short-term investments71
Receivables74
Inventory, net of allowances, customer advances and progress billings64
Inventory64
Prepaid expense and other current assets29
Deferred tax assets13
Other undisclosed current assets25
Total current assets:453
Noncurrent Assets
Property, plant and equipment11
Intangible assets, net (including goodwill)714
Goodwill97
Intangible assets, net (excluding goodwill)618
Deferred costs3
Prepaid expense and other noncurrent assets21
Deferred tax assets, net18
Total noncurrent assets:767
TOTAL ASSETS:1,220
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities119
Accounts payable21
Accrued liabilities84
Employee-related liabilities13
Taxes payable1
Other undisclosed current liabilities(5)
Total current liabilities:114
Noncurrent Liabilities
Long-term debt and lease obligation324
Long-term debt, excluding current maturities324
Liabilities, other than long-term debt169
Deferred tax liabilities, net167
Other liabilities2
Other undisclosed noncurrent liabilities(144)
Total noncurrent liabilities:349
Total liabilities:463
Stockholders' equity
Stockholders' equity attributable to parent757
Common stock0
Treasury stock, value(350)
Additional paid in capital790
Accumulated other comprehensive loss(3)
Retained earnings320
Total stockholders' equity:757
TOTAL LIABILITIES AND EQUITY:1,220

Income statement (P&L) ($ in millions)

12/31/2012
Revenues
(Revenue, Net)
428
Cost of revenue
(Cost of Goods and Services Sold)
(109)
Gross profit:319
Operating expenses(286)
Operating income:33
Nonoperating expense(0)
Investment income, nonoperating1
Other nonoperating expense(1)
Interest and debt expense(14)
Income from continuing operations before income taxes:19
Income tax expense(13)
Net income available to common stockholders, diluted:6

Comprehensive Income ($ in millions)

12/31/2012
Net income:6
Comprehensive income:6
Other undisclosed comprehensive income, net of tax, attributable to parent0
Comprehensive income, net of tax, attributable to parent:6

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: